Sanofi-Aventis Setback Could Mean Generic Biotech Drugs Are On The Way – Forbes (blog)
By admin
|
Sanofi-Aventis Setback Could Mean Generic Biotech Drugs Are On The Way
Forbes (blog) … move ahead with generic versions of protein drugs made through genetic engineering, a move that could deeply impact Amgen and other biotech companies. … |
July 24th, 2010
This author published 8935 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research